Chase A et al.Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.Haematologica 98:103-6 (2013).
WB
;
Human
.
PubMed: 22875613
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"